Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × durvalumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Small Cell Lung Carcinoma 9 Urinary Bladder Neoplasms 6 Neoplasms 6 Carcinoma, Hepatocellular 6 Cholangiocarcinoma 5 Biliary Tract Neoplasms 5 Liver Neoplasms 4 Neoplasms by Site 3 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Stomach Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Diseases 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

Carboplatin 7 Cisplatin 6 pembrolizumab 5 Radiotherapy 5 Paclitaxel 4 Cetuximab 4 Drug Therapy 3 toripalimab 2 osimertinib 2 X-Rays 2 Fulvestrant 2 Fluorouracil 2 Chemoradiotherapy 2 trastuzumab deruxtecan 1 tisotumab vedotin 1 tislelizumab 1 ribociclib 1 pralsetinib 1 pamiparib 1 palbociclib 1 monalizumab 1 fludarabine 1 exemestane 1 entrectinib 1 disitamab vedotin 1 Therapeutics 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡